Lymphomas
PRELUDE: A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Trial ID: 05007
Contact: Sharon Pritchard
Phone: (281)863-6685
Learn More about this trial.
go back | new search